I

Immuneering Corp
D

IMRX

2.03000
USD
-0.06
(-2.87%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-1
Market Cap
63,032,409
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    181.140 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    280.01 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    154.520 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    789.25 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.620 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.797 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.760 USD
    More
News

Title: Immuneering Corp

Sector: Healthcare
Industry: Biotechnology
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.